|
|
||||||||
J Thorac Cardiovasc Surg 2000;120:660-667
© 2000 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
From the Cardiac Surgical Research Unit,a Alfred Hospital, Baker Medical Research Institute, and the Department of Surgery, Monash University; the Department of Epidemiology and Preventative Medicine,b Monash University; and the Department of Biochemistry and Molecular Biology,c Monash University, Melbourne, Australia.
Supported in part by Rothschild Australia. Dr J. Mariani was supported by a Monash University Bachelor of Medical Science Scholarship and an Alfred Hospital Medical Scholarship. Dr S. Pepe was supported in part by the National Heart Foundation of Australia. Dr F. Rosenfeldt is an National Health and Medical Research Council Principal Research Fellow.
Address for reprints: Franklin Rosenfeldt, MD, FRACS, Associate Professor, Cardiac Surgical Research Unit, Alfred Hospital & Baker Medical Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria 8008, Australia (E-mail: f.rosenfeldt{at}alfred.org.au).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although distinct differences in myocardial function between aged and young adults have been described in animal models,
9-11 there is a dearth of direct examination of the influence of age on postischemic or posthypoxic recovery of human myocardial contractile function. Although various controlled stresses can be readily generated in senescent myocardium in animals and the response can be accurately quantified, this is not readily achievable in human subjects. The aim of this study was to directly examine, under controlled conditions, whether age-associated differences are evident in the recovery of contractile function in human atrial myocardium after exposure to hypoxia or ischemia in vitro.
| Methods |
|---|
|
|
|---|
Individual muscle strips were connected to a Grass FT03 force transducer (Grass Instrument Division, West Warwick, RI) and held between two platinum field-stimulation electrodes (normoxia and hypoxia). For simulated ischemia experiments, the tissue was stimulated by direct contact with punctate electrodes. The muscle preparation was lowered into 2,3-butanedione monoximefree Ringer's solution in a water-jacketed tissue bath kept at 37°C, and partial pressure of oxygen (PO2) was maintained above 600 mm Hg. The bathing solution was replaced to remove residual 2,3-butanedione monoxime before the experiment was begun. During the initial stabilization period, tissues were maintained unstretched and field stimulated at 1 Hz with a 10-ms square wave pulse by means of an isolated stimulator (Grass ST48). Transduced muscle contraction was recorded with a Neomedix 8-channel recorder (Neomedix Systems Pty Ltd, Warriewood, New South Wales, Australia).
Contractile function assessment protocol
After 30 minutes of stabilization, each muscle strip was stretched incrementally over 20 minutes to a length-developing maximum force (Lmax). A further 30 minutes of stabilization ensued after the tissues were superfused with fresh modified Ringer's solution. At the end of this period (t = 0), the following steady-state contractile function variables were assessed: resting force (RF; in milligrams); developed force (DF; in milligrams); contraction duration (CD; in milliseconds); time to peak tension (tPT; in milliseconds); and time to 50% relaxation (tR50%; in milliseconds).
Approximately 3 to 5 pectinate trabeculae of appropriate size were dissected from each right atrial appendage. When the right atrial appendage sample was large enough, one randomly selected trabecula was allocated to a time control group that remained normoxic for the entire experimental period (90 minutes). The remaining 2 to 3 trabeculae were subjected to hypoxia or, in separate experiments, simulated ischemia.
In the time control group trabeculae from 32 patients (20 men and 12 women; age, 62.2 ± 12.4 years) were maintained in normoxic perfusate to determine muscle strip steady-state contractile performance during the entire experimental period. Contractile function was measured at 4 time intervals (t = 0, 30, 60, and 90 minutes) and expressed relative to the initial steady-state performance (t = 0 minutes).
In the hypoxia group, after initial contraction assessment under normoxic conditions, trabeculae from 38 patients (24 men and 14 women; age, 62.0 ± 11.7 years) were subjected to 30 minutes of hypoxia. Hypoxia was induced by reducing PO2 to 45 ± 3 mm Hg in the Ringer's solution by bubbling with 95% N2/5% CO2, and tissues were electrically stimulated at 2 Hz.
In the simulated ischemia group, after normoxic assessment, trabeculae from 20 patients (13 men and 7 women; age, 60.9 ± 10.3 years) were subjected to 30 minutes of ischemia, which was simulated by impeding oxygen and metabolic substrate delivery while permitting tissue metabolite accumulation. The bath was sealed, and the Ringer's solution was drained to expose the muscle strip to superfusion with humidified 95% N2/5% CO2 at 37°C. The tissue was paced at 2 Hz by means of direct punctate electrode stimulation.
After hypoxia or ischemia, tissues were allowed normoxic recovery paced at 1 Hz for 30 minutes, and postanoxic function was measured for comparison with pre-stress contractile function. Trabecular length under tension and weight was determined at the end of each experiment to calculate cross-sectional area. Cross-sectional area was calculated by dividing muscle mass by the product of length and density, assuming a cylindrical shape and a density of 1.06 mg/mm3.
12 Tissues with a cross-sectional area of greater than 1.2 mm2 were excluded from the study because larger tissues are more likely to have an anoxic core.
13 DF and RF values were normalized for cross-sectional area so that tension was not affected by variable muscle size.
Statistical analysis
Because trabeculae from each patient could not be considered morphologically identical, the measures for each variable of 3 to 4 trabeculae per patient were analyzed individually, and the within-patient and between-patient variance was calculated by PROC MIXED software (SAS version 6.12; SAS Institute Inc, Cary, NC). Final values per treatment group of patients are presented as means ± SD. Differences in contractile function variables between treatment groups were assessed by the 1-way analysis of variance (ANOVA) and the Student-Newman-Keuls test for multiple comparisons. Linear regression analysis was used to determine the correlations between age and post-stress recovery of contractile function. Significant (P < .05) clinical predictors of recovery of contractile function were identified by univariate analysis, which was performed with 1-way ANOVA, linear regression, and a t test where appropriate. These predictors were then entered into a multivariate stepwise forward linear regression model, with contractile function as the outcome variable. The order in which variables were entered was alternated to determine the optimum predictive model. Analyses were performed by use of SAS version 6.12.
| Results |
|---|
|
|
|---|
2 = 0.545, P = .76). The physical and the baseline steady-state contractile function characteristics of pectinate trabeculae from the 58 patients are summarized inTable I. Steady-state contractile performance assessed immediately before induction of the hypoxic or ischemic stress periods was determined for each trabecula. Length at Lmax, blotted weight, cross-sectional area, and all measured variables of normoxic contractile function were similar for all the age groups.
|
|
Contractile function before and after 30 minutes of hypoxia was recorded in each trabecula (n = 73) from 38 patients, and the effect of hypoxia was assessed. For the whole group, there was a significant reduction in DF (54.4% ± 22.2%), tPT (87.7% ± 9.8%), tR50% (85.6% ± 12.3%), and CD (86.6% ± 10.5%; for each variable, P < .0001). Posthypoxic RF (308 ± 154 mg) was not statistically significant (P = .3) compared with prehypoxic RF (285 ± 129 mg). The resultant modest reduction of posthypoxic contractile variables indicates that the hypoxic stress used was of intermediate severity, produced only a mild hypoxic contracture, and permitted post-stress recovery of contraction.Fig 1, A, shows that the aged (70-89 years) and intermediate (60-69 years) groups had significantly less posthypoxic recovery of DF than the youngest group (34-59 years). No significant difference was observed among the 3 age groups for any other variable(Table II
).
|
The groups of 70- to 89-year-old and 60 to 69-year-old subjects had significantly less recovery of DF than the group of 34- to 60-year-old subjects (P = .007;Fig 1
, B). As seen after hypoxia, no age-related differences were observed for other contractile variables(Table II
). Linear regression analysis indicated there was a highly significant linear relationship between the reduced postischemic recovery of DF and increased age (r2 = 0.54, P = .0002;Fig 1
, C).
Analysis of poststress recovery of contraction and patient clinical variables
Individual patient characteristics, assessed before or during the operation, were first compared as univariate predictors of recovery. Of 21 variables(Table III), age (P = .01), hypertension (P = .01), prior treatment with nitrates (P = .02), and Ca2+ channel antagonists (P = .01) were significant factors associated with reduced recovery of DF after either hypoxia or simulated ischemia. However, when multivariate stepwise forward linear regression was performed, only age (parameter estimate = 0.7324 ± 0.213, P = .001) and hypertension (parameter estimate = 11.0159 ± 4.97, P = .03) were significant independent predictors of diminished recovery of DF after hypoxic or ischemic stress. Multivariate linear regression of other contractile function variables (RF, tPT, tR50%, and CD) indicated that age and hypertension had no predictive effect on poststress outcome. However, of all the clinical variables, multivariate linear regression revealed that only the prior treatment with angiotensin-converting enzyme inhibitor had an effect on post-stress CD (angiotensin-converting enzyme inhibitor group CD = 79.5 ± 8.3 ms, n = 13; without CD = 89.6 ± 9.4 ms, n = 45; parameter estimate = 2.2383 ± 2.46; P = .001). This effect on CD reflected the prevalence of heart failure in these patients.
|
2 test). However, postoperative inotrope use was unrelated to age (34-59 years = 0/21; 60-69 years = 4/20; 70-89 years = 3/17; P = .1,
2 test). | Discussion |
|---|
|
|
|---|
Isolated human atrial pectinate muscle model
Several studies have used the isolated human atrial pectinate muscle model to assess human myocardial performance in vitro and thus eliminate extrapolation from animal studies.
12,13 We assessed the stability of this model for use in the present study by maintaining contracting muscle strips in normoxic conditions. DF was found to decrease gradually by 21.5% after 90 minutes, which is similar to previous reports.
12,13 Despite this decline, contractile function under normoxic conditions did not differ between the age groups, even after 90 minutes. Thus, the age-associated differences we have observed appear to not be related to deterioration of baseline myocardial performance but rather to a decline with increasing age of intrinsic myocardial tolerance to stress. The implication for cardiac surgery in elderly patients is that although preoperative myocardial performance may appear to be adequate to withstand the overall stress of surgery, the ability to recover function after cardioplegia or episodes of perioperative hypoxia may be severely reduced. The importance of age as a major influence on myocardial susceptibility to hypoxic and ischemic stress is highlighted by the absence of interaction between age and other factors(Table III
). The only other significant predictor identified was hypertension. This might reflect the higher level of sympathetic tone
14 that has been described in hypertension and the perturbations to the intracellular calcium homeostasis of myocytes
9 that may reduce the resistance of the myocardium to stress.
One clear limitation of the present model is the use of atrial rather than ventricular muscle. Not only is access to healthy human myocardial tissue for study purposes rare, but also the limited size of ventricular biopsy samples precludes conventional force transduction experiments in ventricular myocardium. The human atrial trabecular preparation has been validated and well accepted in the study of pharmacologic agents.
13,15 There are clear structural and functional differences between atrial and ventricular tissue,
16 which limit the use of atrial tissue as an experimental surrogate for ventricular myocardium. However, atrial trabeculae may still be a valid indicator of the effect of aging on the intrinsic response of myocardial tissue to ischemic or hypoxic stress. A confounding factor with the use of this model in the present study of aging could be the presence of myocardial disease in the atrial appendage. A substantial effect of myocardial disease is unlikely because this study used only atrial appendages from patients free of overt right heart failure and with normal macroscopic appearance, a finding confirmed in early experiments by histologic examination. More important, no correlation was observed between recovery of atrial strip function after hypoxia and ischemia and any markers of myocardial disease, such as congestive heart failure or the number of diseased vessels(Table III
).
Potential mechanisms of age-associated deficits in postischemic cardiac function
Ischemia of the myocardium leads to a switch from aerobic to anaerobic metabolism, with consequent depletion of high-energy phosphates, accumulation of lactate, acidosis, and loss of intracellular ionic homeostasis.
6,11,17,18 Reperfusion results in augmented oxygen-derived free radical production, cytosolic and mitochondrial calcium overload, and, in cases of severe ischemia, sarcolemmal membrane disruption.
18-20 These adverse events are exaggerated in the senescent myocardium, particularly calcium overload
6,9-11,20 and free radical release,
21-24 with devastating consequences on ion-dependent enzymes, intracellular signaling, and energy production.
6,18-25
Most adenosine triphosphate required for cellular activity is produced in the mitochondrial respiratory chain by oxidative phosphorylation, and key subunits of this system are encoded by mitochondrial DNA.
26 An increase in the abundance of mutant mitochondrial DNA (together with an increase in nuclear somatic mutations) found with advanced age has been implicated in age-associated deficits in mitochondrial function, mainly because of altered free radical activity that leads to the destruction of cellular membrane lipids, proteins, and DNA.
21,23,24,27 Of the various mitochondrial enzymes reported to exhibit altered function in aging,
10,17,21-25,27 the most crucial is cytochrome c oxidase.
23-25 This is the terminal enzyme of the respiratory chain essential for the transfer of electrons to molecular oxygen, and 3 of its largest subunits are encoded by mitochondrial DNA, which are synthesized in mitochondria.
26 Cytochrome c oxidase deficiency has been found to be associated with several overt mitochondrial diseases involving severe metabolic impairment,
28 and it has also been reported to be markedly diminished in cardiac myocytes free from apparent disease in human beings aged 50 to 97 years compared with those aged 14 to 50 years.
25 However, it is evident that the age-associated deficits in myocardial function mainly shown in animal studies and usually apparent only after superimposition of nonphysiologic stress are multifactorial and require detailed molecular investigation in human subjects. Indeed, the biologic significance of mitochondrial DNA mutations and other mitochondrial deficits in senescent human myocardium remains controversial.
In conclusion, the present study in an in vitro model of human atrial pectinate trabeculae has shown that atrial myocardium from elderly subjects has a significantly reduced capacity to recover systolic force after a hypoxic or ischemic stress. Although under normoxic conditions no significant difference was observed in the contractile performance between different age groups, after stress, the recovery of DF was inversely related to the age of the patient undergoing coronary artery bypass grafting. This underlying difference between elderly and younger myocardium has implications for myocardial management during surgery in elderly patients. The intrinsic molecular mechanisms responsible for these age-associated responses require direct investigation, and their definition is critical to design age-specific surgical and pharmacologic therapy.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Golomb, A. Nyska, and H. Schwalb Occult Cardiotoxicity--Toxic Effects on Cardiac Ischemic Tolerance Toxicol Pathol, August 1, 2009; 37(5): 572 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boengler, R. Schulz, and G. Heusch Loss of cardioprotection with ageing Cardiovasc Res, July 15, 2009; 83(2): 247 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Hanouz, L. Zhu, S. Lemoine, C. Durand, O. Lepage, M. Massetti, A. Khayat, B. Plaud, and J.-L. Gerard Reactive Oxygen Species Mediate Sevoflurane- and Desflurane-Induced Preconditioning in Isolated Human Right Atria In Vitro Anesth. Analg., December 1, 2007; 105(6): 1534 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. S. Hwang, M. L. Fung, E. C. Liong, G. L. Tipoe, and F. Tang Age-Related Changes in Adrenomedullin Expression and Hypoxia-Inducible Factor-1 Activity in the Rat Lung and Their Responses to Hypoxia J Gerontol A Biol Sci Med Sci, January 1, 2007; 62(1): 41 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cladellas, J. Bruguera, J. Comin, J. Vila, E. de Jaime, J. Marti, and M. Gomez Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur. Heart J., May 1, 2006; 27(9): 1093 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Riess, A. K. S. Camara, S. S. Rhodes, J. McCormick, M. T. Jiang, and D. F. Stowe Increasing Heart Size and Age Attenuate Anesthetic Preconditioning in Guinea Pig Isolated Hearts Anesth. Analg., December 1, 2005; 101(6): 1572 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pepe and E. G. Lakatta Aging hearts and vessels: Masters of adaptation and survival Cardiovasc Res, May 1, 2005; 66(2): 190 - 193. [Full Text] [PDF] |
||||
![]() |
M. Juhaszova, C. Rabuel, D. B. Zorov, E. G. Lakatta, and S. J. Sollott Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res, May 1, 2005; 66(2): 233 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Willems, K. J. Ashton, and J. P. Headrick Adenosine-mediated cardioprotection in the aging myocardium Cardiovasc Res, May 1, 2005; 66(2): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rosenfeldt, S. Marasco, W. Lyon, M. Wowk, F. Sheeran, M. Bailey, D. Esmore, B. Davis, A. Pick, M. Rabinov, et al. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 25 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Mulligan, A. A. Gonzalez, R. Kumar, A. J. Davis, and K. W. Saupe Aging Elevates Basal Adenosine Monophosphate-Activated Protein Kinase (AMPK) Activity and Eliminates Hypoxic Activation of AMPK in Mouse Liver J Gerontol A Biol Sci Med Sci, January 1, 2005; 60(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bartling, I. Friedrich, R.-E. Silber, and A. Simm Ischemic preconditioning is not cardioprotective in senescent human myocardium Ann. Thorac. Surg., July 1, 2003; 76(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Loubani, S. Ghosh, and M. Galinanes The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 143 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Headrick, L. Willems, K. J Ashton, K. Holmgren, J. Peart, and G P. Matherne Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression J. Physiol., June 15, 2003; 549(3): 823 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Starnes, R. P. Taylor, and Y. Park Exercise improves postischemic function in aging hearts Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H347 - H351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Edwards, D. Sarkar, R. Klopp, J. D. Morrow, R. Weindruch, and T. A. Prolla Age-related impairment of the transcriptional responses to oxidative stress in the mouse heart Physiol Genomics, April 16, 2003; 13(2): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Demaria, M. Carrier, S. Fortier, R. Martineau, A. Fortier, R. Cartier, M. Pellerin, Y. Hebert, D. Bouchard, P. Page, et al. Reduced Mortality and Strokes With Off-Pump Coronary Artery Bypass Grafting Surgery in Octogenarians Circulation, September 24, 2002; 106(12_suppl_1): I-5 - I-10. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Lee, S.-F. Su, T.-F. Chou, Y.-T. Lee, and C.-H. Tsai Loss of Preconditioning by Attenuated Activation of Myocardial ATP-Sensitive Potassium Channels in Elderly Patients Undergoing Coronary Angioplasty Circulation, January 22, 2002; 105(3): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pepe Dysfunctional ischemic preconditioning mechanisms in aging Cardiovasc Res, January 1, 2001; 49(1): 11 - 14. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |